project id: TCGA-READ; case submitter id: TCGA-AH-6903; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 46; days to birth: -17030; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1964; age at diagnosis: 17030; ajcc pathologic m: M0; ajcc pathologic n: N1b; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 592.0; icd 10 code: C19; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; weight: 16.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.4; longest dimension: 0.4; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-AH-6903-01A-11; percent necrosis: 3.0; percent normal cells: 3.0; percent stromal cells: 25.0; percent tumor cells: 69.0; percent tumor nuclei: 75.0;